ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 29,900 shares, a growth of 25.6% from the November 30th total of 23,800 shares. Approximately 4.4% of the company’s shares are short sold. Based on an average daily trading volume, of 110,300 shares, the short-interest ratio is presently 0.3 days.

ReShape Lifesciences Trading Down 4.2 %

Shares of RSLS stock traded down $0.20 on Friday, reaching $4.55. 7,377 shares of the stock were exchanged, compared to its average volume of 93,427. The firm has a 50 day moving average of $5.31 and a two-hundred day moving average of $8.10. ReShape Lifesciences has a 1-year low of $4.09 and a 1-year high of $29.00.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.